Prolonged alveolocapillary barrier damage after acute cardiogenic pulmonary edema

Critical Care Medicine

Volumn 31, Issue 4, 2003, Pages 1060-1067

  De Pasquale, Carmine G ^a   Arnolda, Leonard F ^a   Doyle, Ian R ^a   Grant, Robyn L ^a   Aylward, Phillip E ^a   Bersten, Andrew D ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Adult; Congestive; Heart failure; Pulmonary edema; Pulmonary surfactant associated proteins; Respiratory distress syndrome; Tumor necrosis factor

Indexed keywords

FUROSEMIDE; GLYCEROL NITRATE; MORPHINE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEMODYNAMIC MONITORING; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; LUNG ALVEOLUS; LUNG CAPILLARY; LUNG EDEMA; LUNG FLUID; LUNG PARENCHYMA; MALE; OBSERVATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS SYNDROME; THORAX RADIOGRAPHY;

ACUTE DISEASE; AGED; CAPILLARY PERMEABILITY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY ALVEOLI; PULMONARY EDEMA; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037387625     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000059649.31659.22     Document Type: Article

References (63)

1. Bachofen H, Schurch S, Weibel ER: Experimental hydrostatic pulmonary edema in rabbit lungs: Barrier lesions. Am Rev Respir Dis 1993; 147:997-1004
2. Crapo JD: New concepts in the formation of pulmonary edema. Am Rev Respir Dis 1993; 147:790-792
3. Baldwin DR, Wise R, Andrews JM, et al: Microlavage: A technique for determining the volume of epithelial lining fluid. Thorax 1991; 46:658-662
4. Sprung CL, Rackow EC, Fein A, et al: The spectrum of pulmonary edema: Differentiation of cardiogenic, intermediate, and non-cardiogenic forms of pulmonary edema. Am Rev Respir Dis 1981; 124:718-722
5. Matthay MA, Folkesson HG, Campagna A, et al: Alveolar epithelial barrier and acute lung injury. New Horiz 1993; 1:613-622
6. West JB, Mathieu-Costello O: Vulnerability of pulmonary capillaries in heart disease. Circulation 1995; 92:622-631
7. Wagner PD, Gale GE, Moon RE, et al: Pulmonary gas exchange in humans exercising at sea level and simulated altitude. J Appl Physiol 1986; 61:260-270
8. Hopkins SR, Schoene RB, Martin TR, et al: Intense exercise impairs the integrity of the pulmonary blood-gas barrier in elite athletes. Am J Respir Crit Care Med 1997; 155:1090-1094
9. Cohen AB, Stevens MD, Miller EJ, et al: Neutrophil-activating peptide-2 in patients with pulmonary edema from congestive heart failure or ARDS. Am J Physiol 1993; 264(5 Pt 1):L490-L495
10. Nakos G, Pneumatikos J, Tsangaris I, et al: Proteins and phospholipids in BAL from patients with hydrostatic pulmonary edema. Am J Crit Care Med 1997; 155:945-951
11. Gunther A, Seibert C, Schmidt R, et al: Surfactant alterations in severe pneumonia, acute respiratory distress syndrome and cardiogenic lung edema. Am J Respir Crit Care Med 1996; 153:176-184
12. Bunnell E, Pacht ER: Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148:1174-1178
13. Zhu S, Ware LB, Geiser T, et al: Increased levels of nitrate and surfactant protein A nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 2001; 163:166-172
14. Starling EH: On the absorption of fluids from the connective tissue spaces. J Physiol 1896; 119:312-326
15. Kramer K, Kirkman P, Kitzman D, et al: Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization. Am Heart J 2000; 140:451-455
16. Yokoyama TM, Vaca L, Rossen RD, et al: Cellular basis for the negative inotropic effects of TNF α in the adult mammalian heart. J Clin Invest 1993; 92:2303-2312
17. Levine B, Kalman J, Mayer L, et al: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323:236-241
18. Torre-Amione G, Kapadia S, Benedict C, et al: Proinflammatory cytokine levels in patients with depressed left ventricular ejection faction: A report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27:1201-1206
19. Bozkurt B, Torre-Amione G, Warren MS, et al: Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation 2001; 103:1044-1047
20. Doyle IR, Nicholas TE, Bersten AD: Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152:307-317
21. Doyle IR, Bersten AD, Nicholas TE: Surfactant proteins -A and -B are elevated in plasma of patients with acute respiratory failure. Am J Respir Crit Care Med 1997; 156:1217-1229
22. Doyle IR, Hermans C, Bernard A, et al: Clearance of Clara cell secretory protein (CC16) and surfactant proteins A and B from blood in acute respiratory failure. Am J Respir Crit Care Med 1998; 158:1528-1535
23. Bersten AD, Holt AW, Vedig AE, et al: Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by facemask. N Engl J Med 1991; 325:1825-1830
24. Killip T, Kimball JT: Treatment of myocardial infarction in a coronary care unit: A two-year experience with 250 patients. Am J Cardiol 1967; 20:457-464
25. Pistolesi M, Giuntini C: Assessment of extravascular lung water. Radiol Clin North Am 1978; 16:551-574
26. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 1980; 47:1-9
27. Pittet JF, Mackersie RC, Martin TR, et al: Biological markers of acute lung injury: Prognostic and pathogenic significance. Am J Respir Crit Care Med 1997; 155:1187-1205
28. Hermans C, Bernard A: Lung epithelium-specific proteins: Characteristics and potential applications as markers. Am J Respir Crit Care Med 1999; 159:646-678
29. Doyle IR, Nicholas TE, Bersten AD: Partitioning lung and plasma proteins: circulating surfactant proteins as biomarkers of alveolocapillary permeability. Clin Exp Pharmacol Physiol 1999; 26:185-197
30. Hermans C, Dong P, Robin M, et al: Renal function as a determinant of circulating SP-A, SP-B and CC16. Abstr. Am J Respir Crit Care Med 2001; 163:A142
31. Kuroki Y, Tsutahara S, Shijubo N, et al: Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis. Am Rev Respir Dis 1993; 147:723-729
32. Honda Y, Kuroki Y, Matsuura E, et al: Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995; 152:1860-1866
33. Kida KH, Oda H, YamanoY, et al: Effects of cigarette smoking on the serum concentration of lung surfactant protein A (SP-A). Eur Respir J 1997; 10:2124-1226
34. Greene KE, Wright JR, Steinberg KP, et al: Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999; 160:1843-1850
35. Takahashi H, Fujishima T, Koba H, et al: Serum surfactant proteins A and D as prognostic factors inn idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 2000; 162:1109-1114
36. Bersten AD, Hunt T, Nicholas TE, et al: Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure. Am J Respir Crit Care Med 2001; 164:648-652
37. Erdmann AJ, Vaughan TR, Brigham KL, et al: Effect of increased vascular pressure on lung fluid balance in anaesthetized sheep. Circ Res 1975; 37:271-284
38. Finlayson JK, Luria MN, Stanfield CA, et al: Hemodynamic studies in acute pulmonary edema. Ann Intern Med 1961; 54:244-253
39. West JB, Tsukimoto K, Mathieu-Costello O, et al: Stress failure in pulmonary capillaries. J Appl Physiol 1991; 70:1731-1742
40. Elliot AR, Fu Z, Tsukimoto KO, et al: Short-term reversibility of ultrastructural changes in pulmonary capillaries caused by stress failure. J Appl Physiol 1992; 73:1150-1158
41. Okada M, Matsumori A, Ono K, et al: Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol 1998; 18:894-901
42. Hishikawa K, Luscher TF: Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. Circulation 1997; 96:3610-3616
43. Kuebler WM, Ying X, Singh B, et al: Pressure is proinflammatory in lung venular capillaries. J Clin Invest 1999; 104:495-502
44. Folkesson HG, Matthay MA, Westrom BR, et al: Alveolar clearance of protein. J Appl Physiol 1996; 80:1431-1445
45. Vlassara H, Brownlee M, Manogue KR, et al: Cachectin/TNF and Il-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science 1988; 240;1546-1548
46. Tran Van Nhieu J, Misset B, Lebargy F, et al: Expression of tumor necrosis factor-alpha gene in alveolar macrophages from patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147:1585-1589
47. Kurz RW, Stockenhubur F, Gremmel F, et al: Serum concentrations of immune parameters during acute cardiogenic pulmonary edema. Crit Care Med 1992; 20:1235-1242
48. Kapadia S, Oral H, Lee JR, et al: Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ Res 1997; 81:187-195
49. Guntupalli KK. Acute pulmonary edema. Cardiol Clin 1984; 2:183-200
50. Beutler BA, Milsark IW, Cerami A: Cachectin/Tumor Necrosis Factor: Production, distribution, and metabolic fate in vivo. J Immunol 1985; 135:3972-3977
51. Bocci V: Interleukins: Clinical pharmacokinetic and practical implications. Clin Pharmacokinet 1991; 21:274-284
52. Maury CPJ, Teppo AM: Circulating TNF-α (cachectin) in myocardial infarction. J Intern Med 1989; 225:333-336
53. Bemelmans MHA, van Tits LJH, Buurman WA: Tumor necrosis factor: Function, release and clearance. Crit Rev Immunol 1996; 16:1-11
54. McRitchie DI, Isowa N, Edelson JD, et al: Production of tumor necrosis factor alpha by primary cultured rat alveolar epithelial cells. Cytokine 2000; 12:644-654
55. Tutor JD, Mason CM, Dobard E, et al: Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med 1994; 149:1107-1111
56. Tremblay L, Valenza F, Ribeiro SP, et al: Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997; 99:944-952
57. Chiumello D, Pristine G, Slutsky AS: Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 160:109-116
58. Hocking DC, Phillips PG, Ferro TJ, et al: Mechanisms of pulmonary edema induced by tumor necrosis factor α. Circ Res 1990; 67:68-77
59. Verghese GM, Ware LB, Matthay BA, et al: Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema. J App Physiol 1999; 87:1301-1312
60. Sharp JT, Griffith GT, Bunnell IL, et al: Ventilatory mechanics in pulmonary edema in man. J Clin Invest 1958; 37:111-117
61. Light RW, George RB: Serial pulmonary function in patients with acute heart failure. Arch Intern Med 1983; 143:429-433
62. Matthay MA, Wiener-Kronish JP: Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990; 142:1250-1257
63. Unger KM, Shibel EM, Moser KM: Detection of left ventricular failure in patients with adult respiratory distress syndrome. Chest 1975; 67:8-13